SUSAN GEORGE: Open Payments
NPI 1760176515 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,945 in 203 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,374 · 2025 $2,945
Food & beverage: $2,945
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $299 |
| Supernus Pharmaceuticals, Inc. | 25 | $282 |
| Alkermes, Inc. | 13 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $255 |
| Collegium Pharmaceutical, Inc. | 19 | $234 |
| Vanda Pharmaceuticals Inc. | 11 | $218 |
| Otsuka America Pharmaceutical, Inc. | 19 | $214 |
| Axsome Therapeutics, Inc. | 12 | $208 |
| ABBVIE INC. | 15 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $146 |
Products named: INGREZZA, Qelbree, ARISTADA, CAPLYTA, Jornay PM, REXULTI, Auvelity, VRAYLAR.
Industry payments across FL — which companies pay providers there.
